policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
policy
Dietary Supplement Health and Education Act of 1994
The Dietary Supplement Health and Education Act of 1994, which defines dietary supplements for use in humans, does not apply to products intended for…
policy
Extralabel use of medicated feeds, including veterinary feed directive drugs, for minor species
The AVMA supports regulatory discretion in enforcing extralabel use of medicated feeds in minor species under veterinary oversight.
policy
Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process
To help ensure adequate availability of veterinary drugs, the AVMA supports increased funding of the FDA Center for Veterinary Medicine for the NADA…
policy
Limited prohibition on extralabel drug use
Any regulatory prohibition of extralabel drug use in animals should be science-based and as limited in scope as possible, consistent with protecting…
policy
National Antimicrobial Resistance Monitoring System (NARMS)
The AVMA recognizes the National Antimicrobial Resistance Monitoring System (NARMS) as a resource for information on antimicrobial resistance trends…
policy
Notification to the veterinarian of violative residues in foods of animal origin
Veterinarians have an essential role in preventing such violations and ensuring the appropriate and judicious use of pharmaceuticals on food animal…
policy
Restriction of veterinary biologics to veterinarians' use
The AVMA supports USDA efforts to restrict all veterinary biologics used in disease control programs, those with high incidence of reactions, and…
policy
Sale of human-label drug products to veterinarians
Because there are a limited number of drugs labeled for use in animals, veterinarians need to have access to human-labeled prescription drugs to…
policy
The veterinary profession's role in addressing the opioid epidemic
AVMA strongly recommends that veterinarians, legislators, state veterinary medical boards, and state pharmacy boards work together to create practical…
policy
Unapproved new animal drugs marketed as devices
The AVMA encourages increased enforcement in regulating the marketing of products represented as devices but appearing to be unapproved new animal…
policy
Veterinary compounding
Compounding is the customized manipulation of a drug by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs…
policy
Withdrawal of FDA approval for animal drug products
Loss of an animal drug product can have adverse effects on animal health, animal welfare and food safety.